The aim of this manuscript is to discuss the use of some advances in immunotherapies for cancer from an ethical standpoint. The analysis will be restricted to the application of gene-editing technologies to adoptive T cell immunotherapy
Refolo, P., Pascali, V. L., Spagnolo, A. G., Gene-Editing Technologies in Adoptive T Cell Therapy for Cancer: An Ethical Analysis, in Vertès A, V. A., Smith D, S. D., Qureshi, Q. N., Dowden N, D. N. (ed.), Second Generation Cell and Gene-based Therapies, Elsevier, London 2020: 581- 595. 10.1016/B978-0-12-812034-7.00021-2 [http://hdl.handle.net/10807/145835]
Gene-Editing Technologies in Adoptive T Cell Therapy for Cancer: An Ethical Analysis
Refolo, Pietro
;Pascali, Vincenzo Lorenzo;Spagnolo, Antonio Gioacchino
2020
Abstract
The aim of this manuscript is to discuss the use of some advances in immunotherapies for cancer from an ethical standpoint. The analysis will be restricted to the application of gene-editing technologies to adoptive T cell immunotherapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
